Geffon 250 Mg Tablets

Product Description

Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.

Precise Targeted Therapy for NSCLC

Geffon 250 Mg Tablets are designed for adult patients diagnosed with non-small cell lung cancer that harbors EGFR genetic mutations. By inhibiting the EGFR tyrosine kinase enzyme, the tablets help arrest tumor growth and progression, offering a personalized approach for those who qualify. Its oral formulation enhances patient convenience and compliance with treatment regimens.


Proper Administration and Storage

Always administer Geffon tablets orally as per your physician's prescription. Adhere to the recommended dosage guidelines and consult your healthcare provider before making any changes. For safety and effectiveness, store the tablets in a cool, dry place at temperatures below 30C. Protect from light and moisture to maintain their integrity.